Trial Financial Management Featured Articles
-
Executive Insights From A China-Based Biotech On Selecting A CRO
5/21/2012
Coreen Oei, Ph.D. is the SVP of clinical operations and project management at BeiGene. Oei oversees the execution of clinical trials and the development of budgets and project timelines for BeiGene’s clinical portfolio. Prior to joining BeiGene, she spent 10 years at GlaxoSmithKline where her most recent role was VP, Scientific and Clinical Operations in the Virtual Proof of Concept Unit. Oei recently took time out to answer some questions posed to her by Life Science Leader magazine on her approach to selecting a contract research organization (CRO) from the perspective of a China-based biotech. By Rob Wright, Chief Editor, Life Science Leader magazine
-
A Chief Medical Officer’s Perspective On Selecting A CRO
5/14/2012
Santosh Vetticaden, Ph.D., M.D. is a drug development professional with over 20 years of experience spanning large pharma and biotech across multiple therapeutic areas. He has been involved in trials from Phase I-Phase IV and has been extensively involved in the design, planning, and implementation of global trials. By Rob Wright, Chief Editor, Life Science Leader magazine
-
Navigating The New Med/Legal Landscape
5/2/2012
Imagine you are a physician, and you are concerned about the forthcoming public visibility that will be driven by the Sunshine Act. In the past, you worked with manufacturers on early-stage compounds to assist in the drug development process. Primarily, this was done via participating in a live, weekend advisory board, where you received a total of $1,000 in honorarium for your time. By Lance Hill
-
Streamlining The Workflow of CRCs: Understand the Challenges, Provide Solutions
5/1/2012
Clinical Research Coordinators (CRCs) play a crucial role at sites in ensuring that research is conducted in a GCP-compliant manner. In many cases, processes could be streamlined to foster greater efficiency and quality in operations. In order to improve the processes, the challenges of current workflows must first be understood.
-
Weathering The Sunshine Act
4/4/2012
The Sunshine Act is a provision in the Patient Protection and Affordable Care Act, signed into law in March 2010. The Sunshine Act requires drug companies, medical device manufacturers and group purchasing organizations (GPOs) to report to the Department of Health and Human Services (HHS) certain payments or other transfers of value they make to physicians and teaching hospitals.
-
Online Community Programs - Changing The Game
4/4/2012
Why are online community programs being used to connect physicians and other healthcare professionals (HCP)?
-
Preparing For The Physician's Payment Sunshine Act Of 2009
9/2/2011
Over the past several year interactions between Health Care Providers (HCPs), Health Care Institutions (HCIs) and Life Science organizations (pharmaceutical and medical device) companies have been under increased scrutiny.